1. 樊代明 中国 空军军医大学 中国工程院院士;2013美国医学院院士 Transjugular intrahepatic portosystemic shunt for portal hypertension: 30 years experience from Chin..
2. 樊代明 中国 空军军医大学 中国工程院院士;2013美国医学院院士 Transjugular intrahepatic portosystemic shunt with or without gastro-oesophageal variceal embolisati..
3. 陈孝平 中国 华中科技大学 中国科学院院士 Prognostic Analysis of Postoperative Survival for Ruptured Hepatocellular Carcinoma with or without ..
4. 吴孟超 中国 海军军医大学 中国科学院院士 The diagnostic and prognostic value of MRP8/MRP14 in intrahepatic cholangiocarcinoma
5. Pramod Kumar,Garg 印度 All India Institute of Medical Sciences - Delhi Comparison of 1-day versus 3-day intravenous terlipressin in cirrhosis patients with variceal bleedi..
6. Robert A,De Man 荷兰 Erasmus University The Role of PIVKA-II as a Predictor of Early Hepatocellular Carcinoma Recurrence-Free Survival after..
7. Hendrik,Vilstrup 丹麦 University of Aarhus Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) Hepatic Encephalopathy-A Review of the Pas..
8. Sachin,Wani 美国 University of COLORADO American Society for Gastrointestinal Endoscopy guideline on role of endoscopy in the diagnosis of m..
9. 梁萍 中国 解放军总医院 主任医师 Prognostic and pathological implications of contrast-enhanced ultrasound features in hepatocellular ..
10. Michael,Trauner 奥地利 Medical University of Vienna Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Ci..
11. Thomas,Reiberger 奥地利 Medical University of Vienna Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Ci..
12. 祁兴顺 中国 北部战区总医院 Mechanisms of portal vein tumour thrombus formation and development in patients with hepatocellular ..
13. 程树群 中国 海军军医大学 Mechanisms of portal vein tumour thrombus formation and development in patients with hepatocellular ..
14. Yu,Ming-Lung 中国 高雄医学大学 Utility of combining PIVKA-II and AFP in the sur- veillance and monitoring of hepatocellular carci- ..
15. Namiki,Izumi 日本 MUSASHINO RED CROSS Hospital Utility of combining PIVKA-II and AFP in the sur- veillance and monitoring of hepatocellular carci- ..
16. 陈力元 中国 香港中文大学 Utility of combining PIVKA-II and AFP in the sur- veillance and monitoring of hepatocellular carci- ..
17. 韩国宏 中国 空军军医大学 Transjugular intrahepatic portosystemic shunt for portal hypertension: 30 years experience from Chin..
18. Benjamin,Bonavida 美国 University of California Los Angeles The Role of RKIP in the Regulation of EMT in the Tumor Microenvironment
19. 韩国宏 中国 空军军医大学 Transjugular intrahepatic portosystemic shunt with or without gastro-oesophageal variceal embolisati..
20. Michael B,Fallon 美国 University of Arizona North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in ..